NCT03519529View on ClinicalTrials.gov

Sex Hormone Binding Globulin, Testosterone and Glycemic Control in Patients With Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

April 15, 2018

Study Completion Date

April 20, 2018

Conditions

Type2 Diabetes

All Listed Sponsors

lead

Nanjing First Hospital, Nanjing Medical University

OTHER

NCT03519529 - Sex Hormone Binding Globulin, Testosterone and Glycemic Control in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter